Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

CanSino Raises $748 Million in Shanghai STAR IPO for Vaccines, Including its COVID-19 Candidate

MicuRx Receives $7.8 Million for Phase I/II Trials of Novel Antimicrobial

Cellular Biomedicine Accepts $383 Million Management-led Privatization Offer

Vision Medicals Raises $29 Million to Support Genetic Testing for Infectious Diseases

Exclusive Interview: Perceptive Advisors Launches LianBio with a New Model to Take US Assets to China

Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China